PARNAX LAB
Back to Balance Sheet
|
PARNAX LAB Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹36 Cr | ₹32 Cr | ₹35 Cr | ₹20 Cr | ₹24 Cr |
What is the latest Total Non-Current Liabilities ratio of PARNAX LAB ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹36 Cr |
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹35 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹24 Cr |
How is Total Non-Current Liabilities of PARNAX LAB Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹36 Cr | 13.15 | |
| Mar2025 | ₹32 Cr | -8.50 | |
| Mar2024 | ₹35 Cr | 78.25 | |
| Mar2023 | ₹20 Cr | -18.33 | |
| Mar2022 | ₹24 Cr | - | |
Compare Total Non-Current Liabilities of peers of PARNAX LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PARNAX LAB | ₹128.5 Cr | 1.1% | -1.9% | -14.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
PARNAX LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | 1.1% |
-1.9% |
-14.6% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses